
CAS 1594092-37-1
:AZ191
Description:
AZ191, identified by its CAS number 1594092-37-1, is a chemical compound that has garnered attention in the field of medicinal chemistry, particularly for its potential applications in research related to cellular processes. While specific characteristics such as its molecular formula, structure, and physical properties may vary, AZ191 is generally recognized as a selective inhibitor of certain biological pathways, which can influence cell signaling and proliferation. Its mechanism of action often involves modulation of specific enzymes or receptors, making it a valuable tool in studying various diseases, including cancer. AZ191's solubility, stability, and reactivity are important factors that influence its utility in laboratory settings. As with many chemical substances, safety data sheets and handling guidelines should be consulted to ensure proper usage and to mitigate any potential hazards associated with its handling. Overall, AZ191 represents a significant compound in the ongoing exploration of therapeutic agents and their roles in biological systems.
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 5 products.
AZ191
CAS:AZ191(IC50 of 17 nM) is an effective and specific DYRK1B inhibitor.Formula:C24H27N7OPurity:98.04% - 99.65%Color and Shape:SolidMolecular weight:429.52AZ191
CAS:<p>AZ191 is a monoclonal antibody that recognizes the nuclear envelope protein, lamin B1. It is used as an anti-cancer treatment for squamous cell cancer, mutant melanoma and cervical cancer. AZ191 also has been shown to induce autophagy and caspase-independent cell death in various types of cancer cells in culture. AZ191 inhibits tumor growth by preventing the formation of new blood vessels that supply oxygen and nutrients to the tumor. The antibodies bind to lamin B1 on the nuclear envelope, which blocks the recruitment of other proteins involved in mitosis, leading to a disruption of DNA synthesis and mitotic progression.</p>Formula:C24H27N7OPurity:Min. 95%Molecular weight:429.52 g/mol




